Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union.
| Author | |
|---|---|
| Abstract |
:
In the European Union (EU), legislation allows patients to directly report adverse drug reactions (ADRs) to competent authorities. Five years after its implementation, patient reporting is not equal in all countries. This study aimed to explore key stakeholders' perceptions of patient reporting in four EU countries. |
| Year of Publication |
:
2018
|
| Journal |
:
Public health
|
| Volume |
:
155
|
| Number of Pages |
:
119-128
|
| Date Published |
:
2018
|
| ISSN Number |
:
0033-3506
|
| URL |
:
http://linkinghub.elsevier.com/retrieve/pii/S0033-3506(17)30398-0
|
| DOI |
:
10.1016/j.puhe.2017.11.023
|
| Short Title |
:
Public Health
|
| Download citation |
